Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...
Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...
Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...
SHANGHAI, Jan 30 () - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company ...
A. Metformin has long been a first-line medication for Type 2 diabetes, but it is certainly not the only drug that can help ...
MedPage Today on MSN
Amputation risk in diabetes drops with GLP-1 drugs, study suggests
Association driven by fewer major amputations ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results